Hem › B-cellslymfom › Illinois › Chicago
Kliniska studier för B-cellslymfom i Chicago, IL
12 studier för B-cellslymfom söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RekryterarFas 3
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekryterarFas 1
- The University of Chicago Medical Center (UCMC), Chicago
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekryterarFas 2
- Research Site, Chicago
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RekryterarFas 1
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekryterarFas 1/2
- University of Chicago Medical Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
RekryterarFas 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekryterarFas 3
- Northwestern, Chicago
- University of Chicago, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
RekryterarFas 2
- Robert H Lurie Cancer Center, Chicago
Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
RekryterarFas 2
- Northwestern University, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekryterarFas 1/2
- University of Illinois at Chicago Cancer Center, Chicago
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
RekryterarFas 1/2
- The University of Chicago Medical Center (UCMC), Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekryterarFas 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
B-cellslymfom-studier i andra städer
- New York City, NY19 studier
- Houston, TX16 studier
- Nashville, TN11 studier
- Philadelphia, PA11 studier
- Rochester, MN10 studier
- Baldwin Park, CA9 studier
- Milwaukee, WI9 studier
- Cleveland, OH9 studier
- Salt Lake City, UT8 studier
- Boston, MA8 studier
- Columbus, OH7 studier
- Pittsburgh, PA7 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer58 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Övervikt41 studier
- Lungcancer41 studier
- Äggstockscancer36 studier
- Stroke34 studier
- Kolorektal cancer33 studier
- Hjärtsvikt31 studier
- Övervikt28 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.